According to this new research study on ' Poultry Diagnostics Market Forecast to 2030 - Geography Analysis by Test Type, Disease, and Geography,' the market was valued at US$ 362.90 million in 2022 and is expected to reach US$ 792.70 million by 2030. It is estimated to register a CAGR of 10.3% during 2020-2030.
Poultry diseases are considered as diseases of the poultry flock rather than individual diseases. Symptoms in a few individual birds are usually an indication of a serious problem for the whole poultry firm. The proper diagnosis of poultry diseases depends on three main factors: the identification of vital organs and body structure, knowledge of disease symptoms and lesions, and a systematic plan for examining the bird's body. Timely and accurate diagnosis assists farmers in implementing appropriate treatment measures, preventing the spread of diseases, and minimizing financial losses. The growth of the poultry diagnostics market is attributed to the rising zoonotic disease cases and technological advancements. Also, Government Support and Initiatives is expected to fuel poultry diagnostics market growth in the coming years.
A report by Frontiers S.A. states disease control, high production, product quality, and reasonable production costs as among the main goals of the current poultry industry. The US Department of Agriculture (USDA), in August 2022, announced Salmonella as a common adulterant in breaded and stuffed raw chicken products. Through this declaration, the Food Safety and Inspection Service (FSIS) would ensure highly contaminated products that could make people sick are not sold to consumers. The FSIS would also participate in setting different standards for adulteration, such as zero tolerance or standards based on specific stereotypes.
The Veterinary & A.H. Services (V&AHS) 2022 report reveals that Scheme No. 1 aims to provide necessary Animal Health facilities and clinical aids for livestock to control and contain animal diseases through proper diagnosis, mass immunization, and delivery of rational treatment. Additionally, Assistance to State for Control of Animal Disease (ASCAD) aims to strategically control the prevention and eradication of different economically important diseases of livestock and poultry birds through six components. A few notable of these components include the strategic immunization of livestock and poultry for protecting economically important poultry diseases, and the modernization of existing labs or a new setup of disease diagnostic laboratories. Such government support and initiatives in diagnostics would offer lucrative market opportunities for poultry producers compared to simple diagnosis.
Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, IDVET, Boehringer Ingelheim International GmbH, Zoetis Inc, BioCheck BV, Bioneer Corp, and BioInGenTech Biotechnologies are among the leading companies operating in the poultry diagnostics market. These players focus on expanding and diversifying their market presence, and acquiring a novel customer base, thus tapping prevailing business opportunities in the poultry diagnostics market.
The Chicken Fans, and Food and Agriculture Organization of the United Nation (FAO) are a few of the major primary and secondary sources referred to while preparing the report on the poultry diagnostics market.
Reasons to Buy
Poultry diseases are considered as diseases of the poultry flock rather than individual diseases. Symptoms in a few individual birds are usually an indication of a serious problem for the whole poultry firm. The proper diagnosis of poultry diseases depends on three main factors: the identification of vital organs and body structure, knowledge of disease symptoms and lesions, and a systematic plan for examining the bird's body. Timely and accurate diagnosis assists farmers in implementing appropriate treatment measures, preventing the spread of diseases, and minimizing financial losses. The growth of the poultry diagnostics market is attributed to the rising zoonotic disease cases and technological advancements. Also, Government Support and Initiatives is expected to fuel poultry diagnostics market growth in the coming years.
A report by Frontiers S.A. states disease control, high production, product quality, and reasonable production costs as among the main goals of the current poultry industry. The US Department of Agriculture (USDA), in August 2022, announced Salmonella as a common adulterant in breaded and stuffed raw chicken products. Through this declaration, the Food Safety and Inspection Service (FSIS) would ensure highly contaminated products that could make people sick are not sold to consumers. The FSIS would also participate in setting different standards for adulteration, such as zero tolerance or standards based on specific stereotypes.
The Veterinary & A.H. Services (V&AHS) 2022 report reveals that Scheme No. 1 aims to provide necessary Animal Health facilities and clinical aids for livestock to control and contain animal diseases through proper diagnosis, mass immunization, and delivery of rational treatment. Additionally, Assistance to State for Control of Animal Disease (ASCAD) aims to strategically control the prevention and eradication of different economically important diseases of livestock and poultry birds through six components. A few notable of these components include the strategic immunization of livestock and poultry for protecting economically important poultry diseases, and the modernization of existing labs or a new setup of disease diagnostic laboratories. Such government support and initiatives in diagnostics would offer lucrative market opportunities for poultry producers compared to simple diagnosis.
Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, IDVET, Boehringer Ingelheim International GmbH, Zoetis Inc, BioCheck BV, Bioneer Corp, and BioInGenTech Biotechnologies are among the leading companies operating in the poultry diagnostics market. These players focus on expanding and diversifying their market presence, and acquiring a novel customer base, thus tapping prevailing business opportunities in the poultry diagnostics market.
- In January 2020, Boehringer International GmbH launched VAXXITEK HVT+IBD+ND. The new product provides a strong immune foundation that optimize protection against Marek’s Disease, Infectious Bursal Disease (classic and variant types) and Newcastle Disease.
- In February 2022, Eurofins Scientific Inc. acquired laboratory testing services business of Barrow-Agee Laboratories, LLC. Barrow-Agee Laboratories, LLC. joins a network of laboratories comprising diverse team of food, feed, and supplement scientists that will enhance to provide a broad range of resources, experience, and expertise that enable customers to bring innovative, sustainable, safe products, to the market faster.
By Test Type, Poultry Diagnostics Market-Based Insights
Based on test type, the poultry diagnostics market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (HI), and other diagnostic tests.By Disease, Poultry Diagnostics Market -Based Insights
Based on disease, the global poultry diagnostics market is segmented into avian salmonellosis, avian influenza, Newcastle disease, avian mycoplasmosis, infectious bronchitis, and others. The avian influenza segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR during 2022-2030.The Chicken Fans, and Food and Agriculture Organization of the United Nation (FAO) are a few of the major primary and secondary sources referred to while preparing the report on the poultry diagnostics market.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global poultry diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global poultry diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the poultry diagnostics market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Poultry Diagnostics Market Landscape
5. Poultry Diagnostics Market - Key Industry Dynamics
6. Poultry Diagnostics Market - Global Market Analysis
7. Global Poultry Diagnostics Market - Revenue and Forecast to 2030 - by Test Type
8. Global Poultry Diagnostics Market - Revenue and Forecast to 2030 - by Disease
9. Poultry Diagnostics Market - Revenue and Forecast to 2030 - Geographic Analysis
10. Pre and Post COVID-19 Impact on Poultry Diagnostics Market
11. Poultry Diagnostics Market-Industry Landscape
12. Company Profiles
13. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Thermo Fisher Scientific Inc
- Idexx Laboratories Inc
- Qiagen NV
- Eurofins Scientific SE
- IDVET
- Boehringer Ingelheim International GmbH
- Zoetis Inc
- BioCheck BV
- Bioneer Corp
- BioInGenTech Biotechnologies
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 152 |
| Published | September 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 362.9 Million |
| Forecasted Market Value ( USD | $ 792.7 Million |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
